These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Bottazzo GF; Florin-Christensen A; Doniach D Lancet; 1974 Nov; 2(7892):1279-83. PubMed ID: 4139522 [No Abstract] [Full Text] [Related]
29. Congenital rubella syndrome as a model for type 1 (insulin-dependent) diabetes mellitus: increased prevalence of islet cell surface antibodies. Ginsberg-Fellner F; Witt ME; Yagihashi S; Dobersen MJ; Taub F; Fedun B; McEvoy RC; Roman SH; Davies RG; Cooper LZ Diabetologia; 1984 Jul; 27 Suppl():87-9. PubMed ID: 6383925 [TBL] [Abstract][Full Text] [Related]
30. [Clinical significance of islet cell antibody and islet cell surface antibody in diabetics]. Iwo K Nihon Rinsho; 1990 Dec; 48 Suppl():300-7. PubMed ID: 2086903 [No Abstract] [Full Text] [Related]
31. HLA antigens, cytoplasmic islet cell antibodies, and carbohydrate tolerance in families of children with insulin-dependent diabetes mellitus. Ginsberg-Fellner F; Dobersen MJ; Witt ME; Rayfield EJ; Rubinstein P; Notkins AL Diabetes; 1982 Apr; 31(4 Pt 1):292-8. PubMed ID: 6759245 [TBL] [Abstract][Full Text] [Related]
32. [Autoimmunological phenomena in diabetes, particularly of the juvenile type]. Dudziński W Pol Tyg Lek; 1977 Sep; 32(39):1525-7. PubMed ID: 335363 [No Abstract] [Full Text] [Related]
33. Islet function in diabetics with persistent islet cell antibodies. Theophanides CG; Pyke DA; Watkins PJ Diabetes; 1978; 27 Suppl 1():265-6. PubMed ID: 344118 [TBL] [Abstract][Full Text] [Related]
34. [Total IgE synthesis in diabetic children]. Cavagni G; Vanelli M; Nori G; Piccione AM; Bernasconi S Arch Fr Pediatr; 1983 Apr; 40(4):319-21. PubMed ID: 6349570 [TBL] [Abstract][Full Text] [Related]
35. Islet-cell antibodies in juvenile diabetes mellitus of recent onset. Lendrum R; Walker G; Gamble DR Lancet; 1975 Apr; 1(7912):880-2. PubMed ID: 47533 [TBL] [Abstract][Full Text] [Related]
36. Non-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies. Maziarz M; Hagopian W; Palmer JP; Sanjeevi CB; Kockum I; Breslow N; Lernmark Å; ; ; Genes Immun; 2015 Dec; 16(8):541-51. PubMed ID: 26513234 [TBL] [Abstract][Full Text] [Related]
37. A population survey of pancreatic islet cell antibodies. Rodger B; Whittingham S; Martin FI; Hawkins BR; Dawkins RL; Welborn TA Clin Exp Immunol; 1980 Jan; 39(1):125-9. PubMed ID: 6993063 [TBL] [Abstract][Full Text] [Related]
38. [4 varieties of islet cell antibodies in 74 insulin-dependent diabetics and their families as a function of the HLA genotype]. Vexiau P; Helmy-Khalil S; Mamoun F; Homberg JC; Cathelineau G; Deschamps I; Busson M; Hors J Presse Med; 1986 Feb; 15(8):383-6. PubMed ID: 2938157 [TBL] [Abstract][Full Text] [Related]
39. Pancreatic islet-cell autoimmunity. Del Prete GF; Betterle C; Bersani G; Romano M; Tiengo A Lancet; 1976 Nov; 2(7994):1090. PubMed ID: 62933 [No Abstract] [Full Text] [Related]
40. Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants. Gorsuch AN; Dean BM; Bottazzo GF; Lister J; Cudworth AG Br Med J; 1980 Jan; 280(6208):145-7. PubMed ID: 6766770 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]